• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ST8SIA1 通过激活 FAK-AKT-mTOR 信号通路调控三阴性乳腺癌的肿瘤生长和转移。

ST8SIA1 Regulates Tumor Growth and Metastasis in TNBC by Activating the FAK-AKT-mTOR Signaling Pathway.

机构信息

Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.

出版信息

Mol Cancer Ther. 2018 Dec;17(12):2689-2701. doi: 10.1158/1535-7163.MCT-18-0399. Epub 2018 Sep 20.

DOI:10.1158/1535-7163.MCT-18-0399
PMID:30237308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6279518/
Abstract

Breast cancer stem-like cells (BCSC) are implicated in cancer recurrence and metastasis of triple-negative breast cancer (TNBC). We have recently discovered that ganglioside GD2 expression defines BCSCs and that ST8SIA1 regulates GD2 expression and BCSC function. In this report, we show that ST8SIA1 is highly expressed in primary TNBC; its expression is positively correlated with the expression of several BCSC-associated genes such as BCL11A, FOXC1, CXCR4, PDGFRβ, SOX2, and mutations in p53. CRISPR knockout of ST8SIA1 completely inhibited BCSC functions, including tumorigenesis and mammosphere formation. Mechanistic studies discovered activation of the FAK-AKT-mTOR signaling pathway in GD2 BCSCs, and its tight regulation by ST8SIA1. Finally, knockout of ST8SIA1 completely blocked tumor growth and metastasis by TNBC cells. In summary, these data demonstrate the mechanism by which ST8SIA1 regulates tumor growth and metastasis in TNBC and identifies it as a novel therapeutic target.

摘要

乳腺癌干细胞样细胞 (BCSC) 与三阴性乳腺癌 (TNBC) 的癌症复发和转移有关。我们最近发现,神经节苷脂 GD2 的表达定义了 BCSC,而 ST8SIA1 调节 GD2 的表达和 BCSC 功能。在本报告中,我们表明 ST8SIA1 在原发性 TNBC 中高度表达;其表达与几个 BCSC 相关基因的表达呈正相关,如 BCL11A、FOXC1、CXCR4、PDGFRβ、SOX2 和 p53 突变。CRISPR 敲除 ST8SIA1 完全抑制了 BCSC 的功能,包括肿瘤发生和类乳腺球体形成。机制研究发现,GD2 BCSC 中 FAK-AKT-mTOR 信号通路被激活,而 ST8SIA1 对其进行了严格的调节。最后,TNBC 细胞中 ST8SIA1 的敲除完全阻断了肿瘤的生长和转移。总之,这些数据表明 ST8SIA1 调节 TNBC 中肿瘤生长和转移的机制,并将其鉴定为一种新的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/182f/6279518/500b6184c881/nihms-1506640-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/182f/6279518/30bad4786ee5/nihms-1506640-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/182f/6279518/b2aec7ebcc2b/nihms-1506640-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/182f/6279518/8775a64b4ffa/nihms-1506640-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/182f/6279518/682a8b61aea8/nihms-1506640-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/182f/6279518/596063d718ee/nihms-1506640-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/182f/6279518/500b6184c881/nihms-1506640-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/182f/6279518/30bad4786ee5/nihms-1506640-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/182f/6279518/b2aec7ebcc2b/nihms-1506640-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/182f/6279518/8775a64b4ffa/nihms-1506640-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/182f/6279518/682a8b61aea8/nihms-1506640-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/182f/6279518/596063d718ee/nihms-1506640-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/182f/6279518/500b6184c881/nihms-1506640-f0006.jpg

相似文献

1
ST8SIA1 Regulates Tumor Growth and Metastasis in TNBC by Activating the FAK-AKT-mTOR Signaling Pathway.ST8SIA1 通过激活 FAK-AKT-mTOR 信号通路调控三阴性乳腺癌的肿瘤生长和转移。
Mol Cancer Ther. 2018 Dec;17(12):2689-2701. doi: 10.1158/1535-7163.MCT-18-0399. Epub 2018 Sep 20.
2
ST8SIA1 inhibition sensitizes triple negative breast cancer to chemotherapy via suppressing Wnt/β-catenin and FAK/Akt/mTOR.ST8SIA1 抑制通过抑制 Wnt/β-catenin 和 FAK/Akt/mTOR 使三阴性乳腺癌对化疗敏感。
Clin Transl Oncol. 2021 Apr;23(4):902-910. doi: 10.1007/s12094-020-02484-7. Epub 2020 Sep 16.
3
Targeting NFκB signaling in GD2 BCSCs.靶向GD2+乳腺癌干细胞中的NFκB信号通路
Aging (Albany NY). 2017 Aug 3;9(8):1847-1848. doi: 10.18632/aging.101274.
4
IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells.BMS-345541对IKK的抑制作用通过靶向GD2 +癌症干细胞来抑制乳腺肿瘤发生和转移。
Oncotarget. 2017 Jun 6;8(23):36936-36949. doi: 10.18632/oncotarget.16294.
5
Ganglioside GD2: a novel therapeutic target in triple-negative breast cancer.神经节苷脂 GD2:三阴性乳腺癌的新治疗靶点。
Ann N Y Acad Sci. 2022 Feb;1508(1):35-53. doi: 10.1111/nyas.14700. Epub 2021 Oct 1.
6
Knockdown of lncRNA MIR4435‑2HG and ST8SIA1 expression inhibits the proliferation, invasion and migration of prostate cancer cells and by blocking the activation of the FAK/AKT/β‑catenin signaling pathway.长链非编码 RNA MIR4435-2HG 和 ST8SIA1 表达的敲低通过阻断 FAK/AKT/β-连环蛋白信号通路的激活抑制前列腺癌细胞的增殖、侵袭和迁移。
Int J Mol Med. 2021 Jun;47(6). doi: 10.3892/ijmm.2021.4926. Epub 2021 Apr 13.
7
Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2 breast cancer stem-like cells.抗 GD2 抗体 dinutuximab 通过靶向 GD2 乳腺癌干细胞样细胞抑制三阴性乳腺癌肿瘤生长。
J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001197.
8
Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway.木樨草素通过 AKT/mTOR 信号通路对 MMP9 表达的表观遗传调控抑制雄激素受体阳性三阴性乳腺癌细胞的增殖和转移。
Phytomedicine. 2021 Jan;81:153437. doi: 10.1016/j.phymed.2020.153437. Epub 2020 Dec 9.
9
Metabolic stress induces GD2 cancer stem cell-like phenotype in triple-negative breast cancer.代谢应激诱导三阴性乳腺癌中 GD2 癌症干细胞样表型。
Br J Cancer. 2022 Mar;126(4):615-627. doi: 10.1038/s41416-021-01636-y. Epub 2021 Nov 22.
10
Increased expression of REG3A promotes tumorigenic behavior in triple negative breast cancer cells.REG3A 的表达增加促进三阴性乳腺癌细胞的致瘤行为。
Breast Cancer Res. 2024 Jun 5;26(1):92. doi: 10.1186/s13058-024-01845-2.

引用本文的文献

1
Matrix metalloproteinase-3 promotes arteriovenous fistula failure by regulating FAK-AKT signaling.基质金属蛋白酶-3通过调节黏着斑激酶-蛋白激酶B信号通路促进动静脉内瘘失功。
bioRxiv. 2025 Aug 30:2025.08.27.672378. doi: 10.1101/2025.08.27.672378.
2
GD3 synthase drives resistance to p53-induced apoptosis in breast cancer by modulating mitochondrial function.GD3合酶通过调节线粒体功能,驱动乳腺癌对p53诱导的细胞凋亡产生抗性。
Oncogene. 2025 May 17. doi: 10.1038/s41388-025-03432-x.
3
Sialyltransferase gene signature as a predictor of prognosis and therapeutic response in kidney renal clear cell carcinoma.

本文引用的文献

1
Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells.SOX2 表达的调控为紫杉醇在乳腺癌干细胞中的有效性划定了一个终点。
Sci Rep. 2017 Aug 23;7(1):9170. doi: 10.1038/s41598-017-08971-2.
2
Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype.神经节苷脂GD3和GD2与生长因子受体的相互作用维持乳腺癌干细胞表型。
Oncotarget. 2017 Jul 18;8(29):47454-47473. doi: 10.18632/oncotarget.17665.
3
IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells.
唾液酸转移酶基因特征作为肾透明细胞癌预后和治疗反应的预测指标
Discov Oncol. 2025 May 16;16(1):785. doi: 10.1007/s12672-025-02566-4.
4
Lipid metabolism involved in progression and drug resistance of breast cancer.脂质代谢与乳腺癌的进展和耐药性有关。
Genes Dis. 2024 Jul 15;12(4):101376. doi: 10.1016/j.gendis.2024.101376. eCollection 2025 Jul.
5
The role of the mTOR pathway in breast cancer stem cells (BCSCs): mechanisms and therapeutic potentials.mTOR信号通路在乳腺癌干细胞(BCSCs)中的作用:机制与治疗潜力
Stem Cell Res Ther. 2025 Mar 29;16(1):156. doi: 10.1186/s13287-025-04218-4.
6
Programmed cell death-related prognostic genes mediate dysregulation of the immune microenvironment in triple-negative breast cancer.程序性细胞死亡相关预后基因介导三阴性乳腺癌免疫微环境的失调。
Front Immunol. 2025 Mar 12;16:1563630. doi: 10.3389/fimmu.2025.1563630. eCollection 2025.
7
The Role of the Fox Gene in Breast Cancer Progression.Fox基因在乳腺癌进展中的作用。
Int J Mol Sci. 2025 Feb 7;26(4):1415. doi: 10.3390/ijms26041415.
8
GD2 is a Crucial Ganglioside in the Signal Modulation and Application as a Target of Cancer Therapeutics.GD2是信号调节中的一种关键神经节苷脂,作为癌症治疗靶点具有应用价值。
Cancer Sci. 2025 Apr;116(4):862-870. doi: 10.1111/cas.70011. Epub 2025 Feb 7.
9
Current status and innovative developments of CAR-T-cell therapy for the treatment of breast cancer.用于治疗乳腺癌的嵌合抗原受体T细胞(CAR-T)疗法的现状与创新进展
Cancer Cell Int. 2025 Jan 4;25(1):3. doi: 10.1186/s12935-024-03615-8.
10
Marine Lectins and Lectin-like Proteins as Promising Molecules Targeting Aberrant Glycosylation Signatures in Human Brain Tumors.海洋凝集素和凝集素样蛋白作为靶向人类脑肿瘤异常糖基化特征的有前景的分子。
Mar Drugs. 2024 Nov 22;22(12):527. doi: 10.3390/md22120527.
BMS-345541对IKK的抑制作用通过靶向GD2 +癌症干细胞来抑制乳腺肿瘤发生和转移。
Oncotarget. 2017 Jun 6;8(23):36936-36949. doi: 10.18632/oncotarget.16294.
4
FOXC1: an emerging marker and therapeutic target for cancer.FOXC1:一种新兴的癌症标志物和治疗靶点。
Oncogene. 2017 Jul 13;36(28):3957-3963. doi: 10.1038/onc.2017.48. Epub 2017 Mar 13.
5
Focal Adhesion Kinase as a Potential Target in AML and MDS.粘着斑激酶作为急性髓系白血病和骨髓增生异常综合征的潜在靶点
Mol Cancer Ther. 2017 Jun;16(6):1133-1144. doi: 10.1158/1535-7163.MCT-16-0719. Epub 2017 Mar 7.
6
FOXC1-induced Gli2 activation: A non-canonical pathway contributing to stemness and anti-Hedgehog resistance in basal-like breast cancer.FOXC1诱导的Gli2激活:一种导致基底样乳腺癌干性和抗Hedgehog耐药性的非经典途径。
Mol Cell Oncol. 2016 Jan 11;3(3):e1131668. doi: 10.1080/23723556.2015.1131668. eCollection 2016 May.
7
FAK mediates a compensatory survival signal parallel to PI3K-AKT in PTEN-null T-ALL cells.在PTEN缺失的T-ALL细胞中,粘着斑激酶(FAK)介导一条与PI3K-AKT平行的代偿性生存信号。
Cell Rep. 2015 Mar 31;10(12):2055-68. doi: 10.1016/j.celrep.2015.02.056. Epub 2015 Mar 19.
8
BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells.BCL11A是一种在干细胞和祖细胞中具有关键功能的三阴性乳腺癌基因。
Nat Commun. 2015 Jan 9;6:5987. doi: 10.1038/ncomms6987.
9
GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer.GD3合酶调节乳腺癌中的上皮-间质转化和转移。
Oncogene. 2015 Jun 4;34(23):2958-67. doi: 10.1038/onc.2014.245. Epub 2014 Aug 11.
10
Breast cancer stem cells: Multiple capacities in tumor metastasis.乳腺癌干细胞:肿瘤转移中的多种能力。
Cancer Lett. 2014 Jul 10;349(1):1-7. doi: 10.1016/j.canlet.2014.03.036. Epub 2014 Apr 12.